Immunic Stock Market Value
| IMUX Stock | USD 0.91 0.04 4.60% |
| Symbol | Immunic |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. Market participants price Immunic higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immunic assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Immunic's market price often diverges from its book value, the accounting figure shown on Immunic's balance sheet. Smart investors calculate Immunic's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Immunic's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunic.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Immunic on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Immunic or generate 0.0% return on investment in Immunic over 90 days. Immunic is related to or competes with Pmv Pharmaceuticals, Relmada Therapeutics, Acrivon Therapeutics, Lite Strategy, Vaxart, Tscan Therapeutics, and Biomea Fusion. Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies fo... More
Immunic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunic upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.66 | |||
| Information Ratio | 0.0632 | |||
| Maximum Drawdown | 22.02 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 11.29 |
Immunic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunic's standard deviation. In reality, there are many statistical measures that can use Immunic historical prices to predict the future Immunic's volatility.| Risk Adjusted Performance | 0.0698 | |||
| Jensen Alpha | 0.3744 | |||
| Total Risk Alpha | (0) | |||
| Sortino Ratio | 0.0746 | |||
| Treynor Ratio | 0.7344 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunic February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0698 | |||
| Market Risk Adjusted Performance | 0.7444 | |||
| Mean Deviation | 4.17 | |||
| Semi Deviation | 3.97 | |||
| Downside Deviation | 4.66 | |||
| Coefficient Of Variation | 1317.51 | |||
| Standard Deviation | 5.5 | |||
| Variance | 30.28 | |||
| Information Ratio | 0.0632 | |||
| Jensen Alpha | 0.3744 | |||
| Total Risk Alpha | (0) | |||
| Sortino Ratio | 0.0746 | |||
| Treynor Ratio | 0.7344 | |||
| Maximum Drawdown | 22.02 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 11.29 | |||
| Downside Variance | 21.75 | |||
| Semi Variance | 15.74 | |||
| Expected Short fall | (5.71) | |||
| Skewness | 0.9097 | |||
| Kurtosis | 1.01 |
Immunic Backtested Returns
Immunic appears to be dangerous, given 3 months investment horizon. Immunic holds Efficiency (Sharpe) Ratio of 0.0925, which attests that the entity had a 0.0925 % return per unit of risk over the last 3 months. By evaluating Immunic's technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please utilize Immunic's Market Risk Adjusted Performance of 0.7444, risk adjusted performance of 0.0698, and Downside Deviation of 4.66 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Immunic holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of 0.56, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immunic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immunic is expected to be smaller as well. Please check Immunic's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Immunic's current trending patterns will revert.
Auto-correlation | -0.55 |
Good reverse predictability
Immunic has good reverse predictability. Overlapping area represents the amount of predictability between Immunic time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunic price movement. The serial correlation of -0.55 indicates that about 55.0% of current Immunic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immunic Stock Analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.